Shenzhen BioX Medical Co., Ltd. is a globally recognized professional manufacturer specializing in high-complexity molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017 and headquartered in Shenzhen—China’s epicenter for biotechnology innovation and advanced medical device manufacturing—BioX Medical has rapidly ascended as a key CE Certified Pathogen Testing Equipment Supplier.
Our commitment to the E-E-A-T principle is reflected in our robust infrastructure: a modern manufacturing facility exceeding 9,000 square meters and a dedicated workforce of over 200 industry specialists. We bridge the gap between academic research and clinical application, providing hospitals, research institutions, and public health organizations with the tools necessary for rapid, accurate pathogen identification.
The future of pathogen testing lies in the ability to detect multiple targets from a single sample. BioX Medical is pioneering 8-channel and 12-channel fluorescence detection systems that reduce "Time-to-Answer" while maintaining clinical-grade sensitivity. Our roadmap includes integrating microfluidic technology to minimize reagent consumption.
We are shifting from simple data output to intelligent clinical decision support. By incorporating machine learning algorithms into our qPCR systems and nucleic acid sequencing platforms, our equipment can now identify atypical amplification curves, reducing the rate of false positives and enhancing laboratory efficiency.
As part of our commitment to Information Gain, BioX Medical is developing IoT-enabled diagnostic platforms. These systems offer real-time remote monitoring, automatic calibration alerts, and secure data transmission to centralized health databases, ensuring global health surveillance readiness.
BioX Medical does not just sell machines; we provide comprehensive diagnostic ecosystems tailored to specific industry verticals.
Rapid-deployable PCR units for airport screenings, border controls, and community-wide pathogen surveillance during outbreaks.
Specialized portable systems for detecting livestock diseases (e.g., ASF, Avian Flu) in the field, preventing economic losses in the food supply chain.
High-throughput automated sample processing systems and sequencers for precision medicine, oncology biomarkers, and genetic rare disease research.
Operating out of Shenzhen gives BioX Medical a unique competitive advantage. Our Factory 4.0 approach integrates lean manufacturing with high-tech automation. This ensures that every piece of Pathogen Testing Equipment we ship meets the rigorous CE certification standards while remaining cost-effective for global healthcare providers.
Navigating international regulatory landscapes is complex. BioX Medical provides full support for local registration, ensuring our products comply with FDA, CE-IVDR, and local health authority requirements. Our OEM and ODM services allow local distributors to provide tailored diagnostic solutions that meet specific regional clinical needs in Europe, North America, and the Asia-Pacific.
We offer virtual and on-site training for lab technicians to ensure optimal equipment utilization and maintenance.
Direct access to clinical evaluation reports, technical files, and certification proofs for seamless importing.
Modern diagnostic procurement departments look for more than just a low price. They seek Reliability, Scalability, and Innovation. BioX Medical addresses these through:
Stable Supply Chain: Mitigating risk through strategic raw material stockpiling.
Technical Support: 24/7 engineering response for critical laboratory downtime.
Sustainability: Energy-efficient laboratory equipment designed for long life cycles.
BioX Medical
